Literature DB >> 20534990

Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study.

Luciane D Miot1, Hélio A Miot, Jossimara Polettini, Márcia G Silva, Mariângela E Marques.   

Abstract

Melasma is a common acquired symmetrical hypermelanosis characterized by irregular light- to dark-brown macules on sun-exposed skin areas. The literature shows few studies on its physiopathogeny. However, changes in α-melanocyte stimulating hormone (α-MSH) secretion and melanocortin-1 receptor (MC1-R) expression may play a role to trigger this condition. Biopsies were taken from both melasma skin and adjacent perilesional normal skin of 44 patients. The biopsies were submitted for hematoxylin and eosin and Fontana-Masson staining and immunohistochemistry with Melan-A, α-MSH, and MC1-R, and processed for transmission electron microscopy. In some cases, they were submitted to MC1-R gene expression analysis by real-time polymerase chain reaction. Increased lymphohistiocytic infiltrate and solar elastosis, higher epidermal melanin were observed in melasma skin. Electron microscopy revealed a greater number of mature melanosomes in keratinocytes and melanocytes, and more prominent cytoplasmic organelles in melasma skin. There was no difference in melanocyte number between areas. However, melanocytes were larger and more dendritic in melasma skin. Immunohistochemistry with α-MSH and MC1-R showed significant labeling in melasmic epidermis but MC1-R messenger ribonucleic acid (RNAm) did not show significant quantitative difference between melasma and normal skin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534990     DOI: 10.1097/DAD.0b013e3181cd4396

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  13 in total

Review 1.  [Melasma : An update on the clinical picture, treatment, and prevention].

Authors:  S Becker; C Schiekofer; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

2.  Sebocytes contribute to melasma onset.

Authors:  Enrica Flori; Arianna Mastrofrancesco; Sarah Mosca; Monica Ottaviani; Stefania Briganti; Giorgia Cardinali; Angela Filoni; Norma Cameli; Marco Zaccarini; Christos C Zouboulis; Mauro Picardo
Journal:  iScience       Date:  2022-02-04

Review 3.  Topical treatment strategies to manipulate human skin pigmentation.

Authors:  Inbal Rachmin; Stephen M Ostrowski; Qing Yu Weng; David E Fisher
Journal:  Adv Drug Deliv Rev       Date:  2020-02-21       Impact factor: 15.470

Review 4.  Confetti-like Sparing: A Diagnostic Clinical Feature of Melasma.

Authors:  Douglas C Wu; Richard E Fitzpatrick; Mitchel P Goldman
Journal:  J Clin Aesthet Dermatol       Date:  2016-02

Review 5.  Participation of keratinocyte- and fibroblast-derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders.

Authors:  Parth R Upadhyay; Tina Ho; Zalfa A Abdel-Malek
Journal:  Pigment Cell Melanoma Res       Date:  2021-05-24       Impact factor: 4.693

Review 6.  Melasma: a clinical and epidemiological review.

Authors:  Ana Carolina Handel; Luciane Donida Bartoli Miot; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

Review 7.  Skin Pigmentation and Pigmentary Disorders: Focus on Epidermal/Dermal Cross-Talk.

Authors:  Emanuela Bastonini; Daniela Kovacs; Mauro Picardo
Journal:  Ann Dermatol       Date:  2016-05-25       Impact factor: 1.444

8.  Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.

Authors:  Emerson V A Lima; Mariana Modesto D A Lima; Mauricio Pedreira Paixão; Hélio Amante Miot
Journal:  BMC Dermatol       Date:  2017-11-28

9.  African ancestry is associated with facial melasma in women: a cross-sectional study.

Authors:  Maria Paula Barbieri D'Elia; Marcela Calixto Brandão; Bruna Ribeiro de Andrade Ramos; Márcia Guimarães da Silva; Luciane Donida Bartoli Miot; Sidney Emanuel Batista Dos Santos; Hélio Amante Miot
Journal:  BMC Med Genet       Date:  2017-02-17       Impact factor: 2.103

10.  Psychometrican analysis and dimensional structure of the Brazilian version of melasma quality of life scale (MELASQoL-BP).

Authors:  Camila Fernandes Pollo Maranzatto; Hélio Amante Miot; Luciane Donida Bartoli Miot; Silmara Meneguin
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.